Quantitative assessment of silicone oil release with siliconized and silicone oil-free syringes by microflow imaging microscopy.


Journal

Arquivos brasileiros de oftalmologia
ISSN: 1678-2925
Titre abrégé: Arq Bras Oftalmol
Pays: Brazil
ID NLM: 0400645

Informations de publication

Date de publication:
15 Jul 2022
Historique:
received: 16 09 2021
accepted: 04 03 2022
entrez: 20 7 2022
pubmed: 21 7 2022
medline: 21 7 2022
Statut: aheadofprint

Résumé

Since particles are released in syringes during intravitreal injections, we assessed them quantitatively after agitating syringes commonly used for intravitreal injections. With and without agitation, the SR 1-ml insulin, Becton-Dickinson Ultra-Fine 0.3-ml Short Needle with a half-unit scale, HSW Norm-Ject Tuberculin, and Becton-Di-ckinson 1-ml Luer Lok Tip were examined with buffer and bevacizumab, aflibercept, and ziv-aflibercept. Flow imaging microscopy was performed to assess the particle numbers, concentrations, morphology, and size distribution. Using the Becton-Dickinson Ultra-Fine syringe, the average particle count after agitation was higher than in the no-agitation group. For particles greater than 10 and 25 µm, differences were observed using the SR syringe between the two studied conditions. There were no significant differences in the means for the other syringes. Without agitation, the SR syringe had the highest number of particles (2,417,361.7 ± 3,421,575.5) followed by the Becton-Dickinson Ultra-Fine with 812.530,9 ± 996.187,2. The Becton-Dickinson Luer Lok Tip and HSW Norm-Ject performed equally with 398,396.8 ± 484,239.2 and 416,016.4 ± 242,650.1 particles, respectively. Flicking syringes to eliminate air bubbles results in increased numbers of particles released during intravitreal injections into the human vitreous.

Identifiants

pubmed: 35857984
pii: S0004-27492022005007206
doi: 10.5935/0004-2749.2021-0320
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Lydianne Lumack do Monte Agra (LLDM)

Hospital de Olhos de Sergipe, Aracaju, SE, Brazil.
Universidade Federal de Sergipe, São Cristovão, SE, Brazil.
Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Natasha Ferreira Santos da Cruz (NFSD)

Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Vaida Linkuviene (V)

Department of Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, CO, USA.

John F Carpenter (JF)

Department of Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, CO, USA.

Michel Eid Farah (ME)

Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Gustavo Barreto Melo (GB)

Hospital de Olhos de Sergipe, Aracaju, SE, Brazil.
Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Maurício Maia (M)

Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Classifications MeSH